Wells Fargo & Company GT BIOPHARMA INC Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024
Number of Shares
10,013
Previous 10,013 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-11 Reduced 0.11%
10,013 $0
Q1 2024

May 10, 2024
BUY
N/A
10,024 New
10,024 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email